NCT00757770 - Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV Vaccine | Biotech Hunter

Enrollment

854

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL

Rotarix

Two oral doses.

BIOLOGICAL

Placebo

Two oral doses; The placebo consist of all components of the study vaccine i.e. excipients and buffer, but no RV particles.

Trial Locations (4)

GSK Investigational Site, Mexico City

GSK Investigational Site, Cali Colombia

GSK Investigational Site

GSK Investigational Site, Lima